How This Low-Debt, High-Return IT Stock Is Diversifying Its Business to Overcome AI Disruption

Synopsis: A traditionally stable, high-return business is undergoing a structural shift. While near-term numbers reflect pressure from AI disruption and segment resets, the transition toward a platform-led, subscription-driven model may redefine its long-term growth trajectory.

For years, this B2B learning platform represented a classic high-quality compounder, predictable growth, strong margins, and an asset-light model delivering consistently high returns on capital. That stability is now evolving into a more complex phase, where the company is simultaneously managing legacy pressures while investing in new growth engines. The result is a transition story that may appear volatile in the short term but could reshape long-term compounding.

With a market capitalisation of ₹2,917 crores, the shares of MPS Limited are trading at ₹1,705 apiece in today’s market session, up 3.57% from its previous day’s close of ₹1,645 apiece. The stock, however, has corrected significantly over the last 6 months, falling by 27.58%.

AI Disruption Creates Short-Term Pressure

The current phase reflects structural adjustment rather than cyclical weakness. In Q3 FY26, revenue declined 2.1% year-on-year to ₹182.5 crore, while net profit fell 12.8% to ₹35.5 crore. However, operating margins remained stable at 31.6%, indicating underlying strength.

The pressure is largely concentrated in the American Journal Experts (AJE) segment, which serves individual researchers and is increasingly exposed to AI-led tools. As AI adoption rises, parts of the traditional author services model are facing disruption.

However, the slowdown is not broad-based. Excluding AJE, the core Research Solutions segment grew 16.2%, while Education Solutions delivered 11.3% growth, suggesting that the underlying business remains stable.

A Business Moving in Multiple Directions

MPS Limited is a global provider of content, platform, and digital learning solutions, serving publishers, educational institutions, and corporates across segments like Research, Education, and CorporaMPS Limited is a global provider of content, platform, and digital learning solutions, serving publishers, educational institutions, and corporates across segments like Research, Education, and Corporate Learning.

The company is no longer a single-engine story. Research Solutions remains stable once adjusted for AJE. Education Solutions is emerging as a key growth driver, supported by long-term contracts and improving margins. Meanwhile, Corporate Learning is undergoing a deliberate reset, as the company exits low-margin projects and shifts toward higher-value, AI-led offerings.

This creates near-term volatility, as different segments operate at different growth and margin trajectories. However, it also reflects a conscious move toward improving revenue quality. The business is effectively transitioning from a predictable linear model to a multi-engine structure, where future growth will come from multiple segments rather than a single core driver.

The Platform Bet Changes the Narrative

The acquisition of Unbound Medicine for $16.5 million marks a strategic shift. Unlike traditional project-based services, Unbound operates a subscription-based platform in healthcare knowledge and clinical decision support. This introduces recurring revenue, stronger client stickiness, and cross-selling opportunities.

Currently operating at around 14% EBITDA margins, management expects improvement toward 30% through integration and synergies. If executed well, this transition could move the company closer to platform-led peers, which typically command higher valuations.

Valuation Reflects Uncertainty, Not Weakness

Despite maintaining strong return ratios, ROCE above 40% and ROE above 30%, the stock trades at around 16–18x earnings. These multiples do not necessarily reflect a deterioration in business quality. Instead, it reflects uncertainty around how the transition will play out.

Execution Will Decide the Outcome

The key challenge now lies in execution. The company must stabilise the Research Solutions segment as AJE faces AI disruption, while ensuring that the Corporate Learning reset translates into higher-margin growth.

The integration of Unbound Medicine is equally critical. Scaling its subscription model, improving margins, and driving cross-selling will determine whether the platform strategy succeeds. As the business becomes more diversified, consistent delivery and clearer communication will be essential to rebuild investor confidence.

Financial Strength Provides Stability

The balance sheet remains a key strength. The company operates with minimal debt and cash reserves of around ₹88 crore. Strong cash generation and high return ratios provide flexibility to invest in new growth areas without financial stress. This cushion becomes particularly important during transition phases, where short-term volatility is expected.

Management Outlook: FY27 as an Inflection Point

Management expects FY26 earnings per share to exceed ₹100, with FY27 shaping up as a potential inflection year. Research Solutions is expected to stabilise as AJE-related pressures reduce. Education Solutions may continue strong growth, supported by contract visibility, while Corporate Learning could recover post restructuring. Unbound Medicine is expected to contribute meaningfully, adding a new growth engine to the business.

Market Takeaway

This is not a turnaround story; it is a transition story. The company is moving from a predictable services model to a platform-led structure. While this introduces short-term uncertainty, it may improve long-term earnings quality and valuation potential. At current levels, the valuation reflects the legacy business, while the success of new growth engines remains unpriced. The key question remains: can execution catch up with ambition?

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post How This Low-Debt, High-Return IT Stock Is Diversifying Its Business to Overcome AI Disruption appeared first on Trade Brains.